REG - Osirium Technologies - Result of General Meeting

Osirium TechnologiesAnnouncement

12/12/2022 10:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221212:nRSL3863Ja&default-theme=true

RNS Number : 3863J  Osirium Technologies PLC  12 December 2022

The information contained within this announcement is deemed by the Company to
constitute inside information pursuant to Article 7 of EU Regulation 596/2014
as it forms part of UK domestic law by virtue of the European Union
(Withdrawal) Act 2018 as amended.

 

12 December 2022

 

Osirium Technologies plc

("Osirium" or the "Company")

Result of General Meeting

Osirium Technologies plc (AIM: OSI), a UK-based leading vendor of cloud-based
cybersecurity software, announces that at the Company's General Meeting, held
earlier today, the resolution put to Shareholders was duly passed on a poll
vote, as follows:

 Resolution                                                        Number of votes for*  % of votes for  Number of votes against  % of votes against  Total number of votes  Votes

                                                                                                                                                                             withheld**
 To authorise allotment and disapply statutory pre-emption rights  10,311,523            99.98%          2,040                    0.02%               10,313,563             7,858

* Includes discretionary votes.

**A vote withheld is not a vote in law and is not counted towards votes cast
"For" or "Against" a resolution.

Accordingly, following the passing of the Resolution at the General Meeting,
the Company has conditionally raised £1.53 million pursuant to the Placing
and Subscription, details of which were announced on 22 November 2022.
Application has been made for the admission of the Second Placing Shares and
Subscription Shares to trading on AIM ("Second Admission") which is expected
to occur on or around 14 December 2022.

Directors' holdings

Details of the interests of the Directors and proposed Director who
participated in the Subscription and their resultant holdings of Ordinary
Shares following Second Admission are as follows:

 Director          Existing number of Ordinary Shares held  Number of Subscription Shares  Total number of Ordinary Shares held following Second Admission  % of enlarged share capital following Second Admission
 Simon Lee         906,083                                  750,000                        1,656,083                                                        1.35%
 David Guyatt(1)   4,913,109                                5,000,000                      9,913,109                                                        8.09%
 Rupert Hutton(1)  253,809                                  500,000                        753,809                                                          0.62%
 Stuart McGregor   146,523                                  750,000                        896,523                                                          0.73%

 (1) includes spouse

Total voting rights

Following Second Admission, the number of Ordinary Shares in issue and number
of voting rights will be 122,548,681. The above figure may be used by
shareholders as the denominator for the calculations by which they will
determine whether they are required to notify their interest in, or a change
to their interest in, the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.

Unless otherwise defined, all capitalised terms used but not defined in this
announcement shall have the meaning given to them in the Circular dated 22
November 2022, a copy of which is available to view on the Company's website,
www.osirium.com (http://www.osirium.com) .

 

 Contacts:

 Osirium Technologies plc                                Tel: +44 (0)1183 242 444
 David Guyatt, CEO
 Rupert Hutton, CFO

 Allenby Capital Limited (Nominated adviser and broker)  Tel: +44 (0)20 3328 5656
 James Reeve / George Payne (Corporate Finance)
 Tony Quirke (Sales and Corporate Broking)

 Alma PR (Financial PR adviser)                          Tel: +44 (0)20 3405 0205
 Hilary Buchanan                                         osirium@almapr.co.uk (mailto:osirium@almapr.co.uk)
 Kieran Breheny
 Will Ellis Hancock

 

 

About Osirium Technologies Plc

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity
software vendor delivering Privileged Access Management (PAM), Privileged
Endpoint Management (PEM) and Osirium Automation solutions that are uniquely
simple to deploy and maintain.

With privileged credentials involved in over 80% of security breaches,
customers rely on Osirium PAM's innovative technology to secure their critical
infrastructure by controlling 3(rd) party access, protecting against insider
threats, and demonstrating rigorous compliance. Osirium Automation delivers
time and cost savings by automating complex, multi-system processes securely,
allowing them to be delegated to Help Desk engineers or end-users and to free
up specialist IT resources. The Osirium PEM solution balances security and
productivity by removing risky local administrator rights from users, while at
the same time allowing escalated privileges for specific applications.

Founded in 2008 and with its headquarters in Reading, UK, the Company's shares
were admitted to trading on AIM in April 2016. For further information please
visit www.osirium.com (http://www.osirium.com/) .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBGBDDLBBDGDD